Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA

IMPORTANCE: HPV DNA screening is an effective approach for the prevention of cervical cancer. The novel real-time recombinase polymerase amplification-based HPV detection systems we developed constitute an improvement over the HPV detection methods currently used in clinical practice and should help to extend cervical cancer screening in the future, particularly in point-of-care test settings.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Microbiology spectrum - 11(2023), 6 vom: 12. Dez., Seite e0120723

Sprache:

Englisch

Beteiligte Personen:

Ying, Jiaxu [VerfasserIn]
Mao, Lingjing [VerfasserIn]
Tang, Yujing [VerfasserIn]
Fassatoui, Meriem [VerfasserIn]
Song, Wei [VerfasserIn]
Xu, Xiaosheng [VerfasserIn]
Tang, Xiaojian [VerfasserIn]
Li, Jing [VerfasserIn]
Liu, Hua [VerfasserIn]
Jian, Fangfang [VerfasserIn]
Du, Qinwen [VerfasserIn]
Wong, Gary [VerfasserIn]
Feng, Weiwei [VerfasserIn]
Berthet, Nicolas [VerfasserIn]

Links:

Volltext

Themen:

Cervical cancer
DNA, Viral
Human papillomavirus
Journal Article
Real-time recombinase polymerase amplification
Recombinases

Anmerkungen:

Date Completed 16.12.2023

Date Revised 16.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1128/spectrum.01207-23

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36281354X